Protection against Cisplatin-Induced Toxicities by N-Acetylcysteine and Sodium Thiosulfate as Assessed at the Molecular, Cellular, and in Vivo Levels
Authors:
- Y. Jeffrey WuYWY. Jeffrey Wu
- Leslie L. MuldoonLMLeslie L. Muldoon
- Edward A. NeuweltENEdward A. Neuwelt
- 1 September 2005
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 314 (3) , 1052-1058
Abstract
Cisplatin (CDDP) is a common, highly toxic chemotherapeutic agent. This study investigates chemoprotective effects of N-acetylcysteine (NAC) and sodium thiosulfate (STS) on in vitro and in vivo CDDP toxicities. For ototoxicity studies, CDDP (6 mg/kg) was administered to rats via a retrograde carotid artery infusion. Auditory brainstem response thresholds at 4 to 20 kHz were tested before and 7 days post-treatment. STS (8 g/m2 i.v.) was administered at 4, 8, or 12 h after CDDP. For nephrotoxicity studies, rats were treated with CDDP intraperitoneally (10 mg/kg) before or after NAC (400 mg/kg) or STS (8 g/m2), and blood urea nitrogen (BUN) and creatinine concentrations were measured after 3 days. In vitro cytotoxicity and chemoprotection in human tumor cell lines were assessed by cell viability and immunoblotting assays. Rats treated with STS 4 h after CDDP exhibited no hearing change. The STS 8-h group had less otoprotection, whereas 12-h rats had ototoxicity. CDDP induced high BUN and creatinine, corresponding to renal tubule toxicities. All NAC-treated animals showed normal BUN and reduced creatinine levels compared with CDDP alone and no histopathological evidence of nephrotoxicity. Delayed STS treatment was not consistently protective against nephrotoxicity. STS administration fully protected against the in vitro cytotoxic and apoptotic effects of CDDP if added within 2 h of CDDP, but chemoprotection decreased if STS administration was 4 h, and was minimal by 6 h, after CDDP. Thus, the chemoprotection route and timing of administration can be manipulated to maintain CDDP antitumor efficacy while protecting against toxicities.Keywords
This publication has 27 references indexed in Scilit:
- Protection against cisplatin-induced ototoxicity by N-acetylcysteine in a rat modelHearing Research, 2004
- Cisplatin nephrotoxicitySeminars in Nephrology, 2003
- Cisplatin Biochemical Mechanism of Action: From Cytotoxicity to Induction of Cell Death Through Interconnections Between Apoptotic and Necrotic PathwaysCurrent Medicinal Chemistry, 2003
- Apoptotic Pathways of Oxidative Damage to Renal Tubular Epithelial CellsAntioxidants & Redox Signaling, 2002
- Strategies for Prevention of Toxicity Caused by Platinum‐Based Chemotherapy: Review and Summary of the Annual Meeting of the Blood–Brain Barrier Disruption Program, Gleneden Beach, Oregon, March 10, 2001The Laryngoscope, 2002
- L‐N‐Acetyl‐Cysteine Protection Against Cisplatin‐Induced Auditory Neuronal and Hair Cell ToxicityThe Laryngoscope, 2001
- Children with Minimal Sensorineural Hearing Loss: Prevalence, Educational Performance, and Functional StatusEar & Hearing, 1998
- d-Methionine provides excellent protection from cisplatin ototoxicity in the ratHearing Research, 1996
- The comparative effects of sodium thiosulfate, diethyldithiocarbamate, fosfomycin and WR-2721 on ameliorating cisplatin-induced ototoxicityHearing Research, 1995
- High-dose cisplatin in patients with advanced malignanciesCancer, 1985